Fady Ibraham Malik - 04 Jan 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John Faurescu, attorney-in-fact for Dr. Malik
Issuer symbol
CYTK
Transactions as of
04 Jan 2024
Net transactions value
-$1,270,756
Form type
4
Filing time
04 Jan 2024, 16:36:11 UTC
Previous filing
09 Nov 2023
Next filing
06 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $92,957 +11,678 +7.7% $7.96 162,651 04 Jan 2024 Direct F1
transaction CYTK Common Stock Sale $1,015,752 -11,678 -7.2% $86.98 150,973 04 Jan 2024 Direct F1
transaction CYTK Common Stock Sale $347,960 -4,000 -2.6% $86.99 146,973 04 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (Right to Buy) Options Exercise $0 -11,678 -100% $0.000000* 0 04 Jan 2024 Common Stock 11,678 $7.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.